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Background: Recovery of upper limb function after stroke is poor. The acute to subacute phase after stroke is the
optimal time window to promote the recovery of upper limb function. The dose and content of training provided
conventionally during this phase is however, unlikely to be adequate to drive functional recovery, especially in the
presence of severe motor disability. The current study concerns an approach to address this shortcoming, through
evaluation of the SMART Arm, a non-robotic device that enables intensive and repetitive practice of reaching by
stroke survivors with severe upper limb disability, with the aim of improving upper limb function. The outcomes of
SMART Arm training with or without outcome-triggered electrical stimulation (OT-stim) to augment movement and
usual therapy will be compared to usual therapy alone.
Methods/Design: A prospective, assessor-blinded parallel, three-group randomised controlled trial is being
conducted. Seventy-five participants with a first-ever unilateral stroke less than 4 months previously, who present
with severe arm disability (three or fewer out of a possible six points on the Motor Assessment Scale [MAS] Item 6),
will be recruited from inpatient rehabilitation facilities. Participants will be randomly allocated to one of three
dose-matched groups: SMART Arm training with OT-stim and usual therapy; SMART Arm training without OT-stim
and usual therapy; or usual therapy alone. All participants will receive 20 hours of upper limb training over four
weeks. Blinded assessors will conduct four assessments: pre intervention (0-weeks), post intervention (4-weeks),
26 weeks and 52 weeks follow-up. The primary outcome measure is MAS item 6. All analyses will be based on an
intention-to-treat principle.
Discussion: By enabling intensive and repetitive practice of a functional upper limb task during inpatient
rehabilitation, SMART Arm training with or without OT-stim in combination with usual therapy, has the potential to
improve recovery of upper limb function in those with severe motor disability. The immediate and long-term
effects of SMART Arm training on upper limb impairment, activity and participation will be explored, in addition to
the benefit of training with or without OT-stim to augment movement when compared to usual therapy alone.
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Recovery of the upper limb after stroke is poor. Up to
80% of stroke survivors have some upper limb disability
during the acute to subacute phase after stroke. By vari-
ous estimates, only 5% to 20% demonstrate complete
functional recovery [1-3]. Thus, stroke survivors with
upper limb disability appear to be a rehabilitation chal-
lenge. There is therefore, a pressing need to increase the
potential for functional recovery of the upper limb after
stroke.
To drive recovery of function, it is recommended that
training commence early and be intensive, repetitive and
task-oriented [4-6]. However, stroke survivors with se-
vere motor disability are often unable to participate in
task-oriented training as they are incapable of generating
levels of volitional motor activity or control that are suffi-
cient to engage in training tasks [7]. Further compounding
their situation is a lack of access to interventions that
make task-oriented practice possible [8]. It is therefore not
surprising that priority is rarely given to upper limb train-
ing by stroke survivors [9] or rehabilitation services
[10-15] during inpatient rehabilitation. Yet, with stroke
survivors spending up to 25% of a physiotherapy session
inactive [15], there appears to be considerable scope
within current therapeutic regimes to increase the delivery
of task-oriented upper limb training.
To capitalise upon this opportunity, a non-robotic
training device, the SMART Arm (Sensori-Motor Active
Rehabilitation Training of the Arm) (Figure 1), was de-
veloped to enable stroke survivors with severe upper
limb disability to undertake intensive and repetitive task-
oriented training. The device was specifically designed
so that stroke survivors with little to no muscle activity
could practice reaching, a fundamental upper limb func-
tion, along a straight-line path consistent with a normalFigure 1 SMART Arm.reaching pattern. The device can be used with or with-
out electrical stimulation to the lateral head of triceps
brachii to augment elbow extension and enhance com-
pletion of the reaching task. To optimise the potential
for motor learning, this device incorporates elements
critical to skill acquisition, including active problem
solving, augmented real-time feedback of performance,
task progression that is tailored to each individual, mo-
tivation and encouragement.
To date, a 12-hour SMART Arm training program
with or without electromyographic (EMG)-triggered
electrical stimulation to triceps has been investigated in
chronic stroke survivors with severe upper limb disabil-
ity. Compared with the control group, those who under-
went SMART Arm training with or without stimulation
showed a significant improvement in upper limb func-
tion (improvement in MAS6 item 6 score) that was
sustained at 2 months follow-up [16], an improved ratio
of triceps to biceps EMG activity during reaching [17],
and greater corticospinal reactivity [18]. There were
however, variations in the expression of additional bene-
fits derived from the use of EMG-triggered electrical
stimulation. As this may have been due to the use, by
some individuals, of maladaptive patterns of EMG activ-
ity such as co-contraction of biceps and triceps, that
could nonetheless trigger stimulation, a new method of
outcome-triggered electrical stimulation (OT-stim) was
developed. Here, electrical stimulation is triggered when
initial goal directed motion surpasses an individualised
threshold. Thus, assistance by means of electrical stimu-
lation (and reinforcement) occurs when the movement
generated voluntarily is commensurate with the desired
outcome. In a pilot trial of SMART Arm with OT-stim
during inpatient rehabilitation, SMART Arm training
(with or without OT-stim), led to a significantly greater
improvement in upper limb function as compared to
usual therapy alone [19]. In that these improvements
were evident early after stroke, further investigation
within the context of a larger trial is warranted [20].
Thus, the primary aim of the current randomised con-
trolled trial (RCT) is to determine the ability of SMART
Arm training with or without OT-stim compared to
usual therapy to improve upper limb function in stroke
survivors with severe upper limb disability undergoing
inpatient rehabilitation. In addition, we will determine
the impact of the different training programs on upper
limb impairment, activity and participation.
Methods/Design
Design
A prospective, assessor-blinded, three group parallel
RCT will be conducted with 75 stroke survivors with se-
vere upper limb disability who are undertaking inpatient
rehabilitation (Figure 2).
Assessed for eligibility 
Pre intervention measurement
Randomization
Allocation to groups
SMART Arm OT-stim
Post intervention measurement
26 weeks follow up measurement
52 weeks follow up measurement
SMART Arm alone Usual care
4 weeks 
26 weeks 
52 weeks 
0 weeks 
Figure 2 Trial design.
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We plan to recruit stroke survivors from two inpatient
rehabilitation services located in Brisbane, Australia: the
Princess Alexandra Hospital, with a six-bed Acute
Stroke Unit, located separately to a 78-bed Geriatric and
Rehabilitation Unit; and the Queen Elizabeth II Jubilee
Hospital, which has a four bed Acute Stroke Unit, co-
located within a 24-bed Geriatric and Rehabilitation
Unit. Assessment and training will be undertaken in dif-
ferent areas of the same site.
Population
All stroke survivors admitted to the Acute Stroke Unit at
each hospital will be screened for eligibility. Participants
will be eligible if they are adult stroke survivors (>17
years) with a primary diagnosis of first-ever unilateral
stroke (ischaemic or haemorrhagic, including subarach-
noid haemorrhage) less than four months previously,
which has been confirmed either radiographically (CT or
MRI) or clinically by the consulting physician; demon-
strate severe upper limb disability equivalent to a score of
three or fewer out of a possible six points (inability to hold
the upper limb in position when placed at 90° shoulderflexion in sitting) on the MAS item six; and are able to fol-
low single-stage commands, either with verbal instruc-
tions, demonstration or other non-verbal cues.
Participants will be excluded if they are medically un-
stable as defined by the medical registrar or by location
in an acute medical ward; have upper limb comorbidities
that could limit their functional recovery (e.g., arthritis,
pain, other neurological disorders); have a contraindica-
tion to the use of (e.g., pacemaker insitu), or inability to
tolerate, electrical stimulation (e.g., hypersensitivity or
skin condition); have an infectious disease requiring the
use of personal protective equipment (e.g., methicillin
resistant staphylococcus aureus or vancomycin resistant
enterococcus) or are unable to sit without support.
Randomisation and blinding
All participants will provide written informed consent.
In the event that a participant is unable to provide in-
formed consent, consent will be sought from their legal
guardian. After completion of the initial assessment, par-
ticipants will be randomised to one of three dose-
matched groups (two intervention and one control). The
intervention groups are SMART Arm training with OT-
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Arm training without OT-stim (SMART Arm alone) and
usual therapy. The control group will receive usual ther-
apy only. Concealed randomisation will be prepared by
an offsite investigator, not involved in recruitment, inter-
vention or data collection, using a computer generated
random number sequence. Consecutively numbered,
randomly ordered opaque envelopes containing group
allocation in permuted blocks of four or six in a 1:1 ratio
will be opened consecutively after baseline assessment in
the presence of the participant. Usual therapists will be
informed of group allocation.
Research assistants who enrol participants, and con-
duct pre, post and follow-up assessments will be blinded
to group allocation throughout the study. Participant
coding will not refer to group allocation and participants
will be instructed not to divulge information regarding
their intervention to the assessors during assessment.
Participants, SMART Arm trainers and usual therapists
(physiotherapy and occupational therapy) will not be
blinded to group allocation. To control expectancy ef-
fects for participants and usual therapists, it will be
explained that it is not yet determined which therapy is
more effective.
Intervention
All participants will receive 20 hours of upper limb ther-
apy, comprising 60 minutes duration five days per week
for four weeks. The proposed volume of training was
guided by discussions with each site and reports from
these [15] and other facilities [21], along with previous
SMART Arm research [16,19]. All SMART Arm training
and usual therapy will be recorded in individual partici-
pant logbooks. If a participant misses a SMART Arm or
usual therapy session due to illness, medical procedure,
or extended leave (e.g., returned to acute medical ward
as became unstable), additional days will be added to en-
sure all participants are given the opportunity to
complete a total of 20-days of therapy.
SMART Arm training
SMART Arm training will be administered for 30 mi-
nutes per day by a physiotherapist or occupational ther-
apist, trained in the delivery of the intervention. The
participant’s treating therapy team will administer 30 mi-
nutes of usual therapy per day. Training will be typically
undertaken five times per week for four weeks.
On commencement of a SMART Arm training session,
the participant will be seated on a (armless) chair beside
the device. A harness will be applied to restrict trunk
movements to less than 15 degrees and therefore, min-
imise compensatory trunk movements and encourage
recovery of a pre-morbid pattern of reaching [22-24].
The affected upper limb will be positioned in acustomised thermoplastic splint in mid pronation-
supination and wrist extension (0 degrees to 45 degrees)
to mimic a functional reach-to-grasp hand position [25].
To accommodate for any muscle contracture or pain,
the splint can be positioned through the full range of
pronation and supination. The splint is connected to a
manipulandum, which is mounted on a linear slide and
encoder belt. The linear slide serves to constrain move-
ment to one plane and to reduce friction and resistance
to movement. The elbow is positioned in a standardized
start position of 90 degrees of elbow flexion.
Trainers will be provided with guidelines for the
administration of SMART Arm training. To ensure
participants perform a consistent minimum number of
repetitions during the training time period (30 minutes),
a goal of a minimum of 60 repetitions in week one and
80 repetitions in weeks two through four will be set. This
dose was guided by previous research [16,19]. Progression
in training difficulty will occur when consistency in
task practice is evident. Training elements that can be
progressed include the number of repetitions, track
elevation, degree of shoulder external rotation, hand
position, load, visual and auditory feedback, instruction and
level of supervision. The decision-making process with
regards to when and how to progress training will be at the
discretion of the SMART Arm trainer and will be based on
the stroke survivor’s performance during training. To
ensure consistency between trainers, monitoring (e.g.,
benchmarking evaluations of completed training logs for
consistent dose, progressions of practice used) and
mentoring (e.g., peer-supervision, feedback during sessions,
and debriefing) will regularly occur. All SMARTArm train-
ing will be documented in a log, which will capture dose
and training element use.Outcome-triggered electrical stimulation The lateral
head of triceps brachii is the target muscle of electrical
stimulation as it is the prime mover for achievement of
full elbow extension. Stimulation to triceps brachii will
be delivered via an Empi 300PV unit (St Paul, MN,
USA). Two surface electrodes (diameter 50 mm) will be
applied, one above the area of the triceps brachii motor
point (lateral head) and one at the muscle insertion.
Stimulation parameters will consist of a 1 second as-
cending ramp, and a 4 to 20 second duration of 200-sec
pulse width biphasic stimulation at 35 Hz. When train-
ing is commenced, the participant will attempt to initiate
the reaching task. As the participants’ reach attempt sur-
passes their individually determined threshold distance,
electrical stimulation to triceps brachii will be automat-
ically triggered. The duration of stimulation provided
will be set manually to match the time required by each
participant to perform the movement. The stimulus
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ated by the participant.
Usual therapy
Participants allocated to usual therapy alone will partici-
pate in 20 therapy sessions of 60 minutes duration, typic-
ally undertaken five days per week for four weeks. Usual
therapy refers to the combined duration of occupational
therapy and physiotherapy. It will not be standardized and
will likely consist of a mix of individual and group sessions
administering both passive (e.g. stretching, cyclic electrical
stimulation) and active (e.g. range of movement, strength-
ening, modified task practice with electrical stimulation)
interventions where possible. All usual therapy will be
documented in an upper limb therapy log, which will cap-
ture dose (minutes), frequency (sessions) and content of
upper limb therapy.
Outcome measures
Arm function (impairment, activity and participation)
will be assessed in accordance with the ICF Classifica-
tion of Functioning, Disability and Health [26]. All par-
ticipants will be assessed at four time points: three days
prior to commencement of the intervention (baseline, 0
weeks), within one week of completion of the interven-
tion (post-intervention, 4 weeks), and following comple-
tion of the intervention at 26 and 52 weeks. Assessors
will be provided with guidelines for administering the
measures.
Demographic information about participants will be col-
lected from their medical record and will include age, gen-
der, date of stroke onset, type (ischaemic or haemorrhagic)
and location (cortical, subcortical, cortical and subcortical
or brainstem) of stroke, stroke medical intervention (e.g.
thrombolysis), co-morbidities and medications.
Primary outcome measure The primary outcome
measure will be performance on the MAS item 6 at the
post intervention time period (4 weeks). The MAS is
designed to measure recovery of the affected limb over 3
task-related subscales (upper arm function, hand and ad-
vanced hand movements) that are scored from 0–6. It is
the stroke recovery scale most commonly used in clin-
ical practice in Australia and takes less than 10 minutes
to complete. The reliability and validity of this measure
with the stroke population has been previously docu-
mented [27]. It has been shown to be sensitive to change
in performance in people with severe upper limb disabil-
ity after training with SMART Arm [16,19].
Secondary laboratory outcome measures The func-
tional force generating capacity of the impaired limb will
be assessed using a dynamic and an isometric reaching
task similar to previous protocols [16,17]. In both tasks,surface EMG activity will be collected from triceps
brachii lateral head, biceps brachii, anterior deltoid,
upper trapezius, external rotators, lower trapezius and
serratus anterior. EMG will be obtained using single dif-
ferential pre-amplified (gain 1000) parallel bar electrodes
(Bagnoli, DELSYS, 8-channel System, Boston, MA,
USA) with a fixed inter-electrode distance of 10 mm
and positioned according to SENIAM guidelines [28].
A reference electrode will be attached over the bony
prominence of the seventh cervical spinous process.
Signals will be sampled (1000Hz) using a Power 1401
Data Acquisition System (Cambridge Electronics Design,
Cambridge, UK) and Spike2 software (version 6.02). Time
series data will be collected and stored using Spike2 and
processed using custom routines in Matlab (Mathworks
Inc., Nattick, MA).
Participants will be seated at a custom-built apparatus
with the upper limb in a pendant position, the elbow
flexed and the forearm and hand restrained in pronation
via a custom built brace. For all measures a computer
monitor positioned directly in front of the participant
will provide visual feedback on a vertical bar scale. In
the dynamic task, the brace will be secured to a
manipulandum mounted on a linear slide restricting
motion of the upper limb to flexion/ extension of the
shoulder and elbow. A potentiometer attached to the
slide will measure transducer, reaching, linear displace-
ment. The upper limb will be placed at a standardised
starting position with the elbow at 90 degrees of flexion.
Upon presentation of a tone, participants will be re-
quired to ‘reach forward as far as possible’ in five separ-
ate trials. In the isometric task, the participant will be
required to push forwards (elbow extension) in a pos-
ition of 150 degrees of elbow flexion against a
manipulandum instrumented to measure force. In five
separate trials, following a tone, participants will be
instructed to ‘push as hard as possible’ and to keep
pushing for five seconds. In both tasks continuous vis-
ual feedback of the applied force will be provided along
with verbal encouragement. During each contraction,
force or reach distance and EMG recordings will be
obtained. On the basis of these recordings, peak force,
distance, time to peak and the muscle onset times,
amplitude (root-mean-square (RMS)) and triceps to bi-
ceps ratio of EMG RMS amplitude will be calculated.
In a subset of the participants, the collection of EMG
signals will be triggered and synchronized using an
OptiTrack™ 6 camera 120 Hz system, with Tracking
Tools™ computer software (NaturalPoint, Inc, OR, USA)
which will collect kinematic data. Upper limb movement
will be tracked via the recording of reflective marker clus-
ters placed on the participants’ upper arm, distal forearm,
sternum, and acromion and acromioclavicular joints.
Kinematic data for analysis will include displacement,
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and markers.
Secondary outcome measures: clinical A range of clin-
ical measures will be collected to measure the presence
of impairments post stroke. To measure strength, lateral
head of triceps brachii muscle power will be assessed
using manual muscle testing according to MRC ratings
from 0–5 [29]. To measure the active range of move-
ment of finger flexion and extension, thumb extension
and abduction, elbow flexion and extension and shoul-
der abduction and adduction, assessment according to
the protocol described by Uswatte et al. [30] will be
performed. To measure the presence of spasticity of bi-
ceps brachii and resistance to passive elbow extension,
the modified Ashworth Scale [31] and Tardieu Scale [32]
will be administered. To evaluate joint tenderness on
passive movement of the hemiplegic shoulder, the
Ritchie Articular Index will be administered [33,34]. To
describe participants at baseline only, the Cognitive Lin-
guistic Quick Test [35] and Nottingham Sensory Assess-
ment [36,37] will be administered. Motor Assessment
Scale items 7 (hand movements) and 8 (advanced hand
activities) will be performed to monitor for any carryover
improvement in hand function. To examine upper limb
function at the participation level, two self-report mea-
sures will be used. The Stroke Impact Scale will be used
to measure the impact of the intervention on the stroke
survivor’s recovery [38]. The Motor Activity Log will be
administered to all subjects to rate how well and how
much they use the paretic limb spontaneously in every-
day tasks [30].
Data analysis
Data analysis will be performed on an intention-to-treat
basis using an alpha level of 0.05. Descriptive statistics
will be used to ensure comparability of scores between
groups at baseline, to describe performance at each
phase and to test whether the assumptions for use of
parametric statistics have been met. If the assumptions
for F or t-tests are violated, equivalent non-parametric
statistics will be utilized. The main hypothesis will be
tested using mixed effects models, in a 3 group (SMART
Arm + OT stim, SMART Arm alone, usual therapy) × 4
phase (0, 4, 26, 52 weeks) model. This will be followed
by between-groups planned comparisons. All secondary
outcomes will be analysed in a similar manner.
Sample size
The principle endpoint is post intervention (4 weeks).
Our previous RCT demonstrated that stroke survivors
using the SMART Arm alone or with electrical stimula-
tion demonstrated significant improvements in MAS-6
scores compared to the control group [16]. On thisbasis, we estimate a mean improvement of 1.8 (SD 2) in
the usual therapy group, 2.91 (SD 2) in the SMART Arm
alone group and 3.91 (SD 2) in the SMART Arm with
OT-stim group. To achieve 80% power and a signifi-
cance of 0.05 with pairwise comparisons, 22 subjects are
required per group, to total 66 subjects. A 15% dropout
rate will be allowed to account for withdrawals, thus 25
subjects will be recruited per group, totalling 75.
Ethics approval
The study protocol has been approved by the University
of Queensland Medical Research Ethics Committee
(MREC ID: 2007001628), and the Princess Alexandra
Hospital Ethics Committee (ID: 2008–046). This study
will be conducted in accordance with the Declaration of
Helsinki.
Discussion
This will be the first prospective trial to compare the ef-
fect of dose-matched volumes of SMART Arm with OT-
stim and usual therapy, versus SMART Arm alone with
usual therapy versus usual therapy alone during in-
patient rehabilitation following stroke. While it is known
that intensive and repetitive, task-oriented training is
critical to drive motor recovery after stroke [39,40],
those with severe impairment and ‘not enough move-
ment to work with’ require assistance to complete a
functional movement pattern. Currently, the most com-
monly used method is manual assistance by a therapist.
The minimal time spent on the upper limb during physio-
therapy indicates however, that this time-inefficient strat-
egy is not prioritised. It is likely that gait training
requirements, which are paramount to determining dis-
charge destination, are prioritised. Another option is ro-
botic therapy, however availability is currently limited and
functional outcomes remain inconclusive [8,41,42].
In the event that SMART Arm training, with or with-
out electrical stimulation, leads to demonstratable sig-
nificant improvements in upper limb function, reduced
impairments or increased participation, an alternative
option for retraining would be presented. Improvements
in impairments and activity using the SMART Arm have
been obtained in chronic stroke survivors [16], and the
indications from our pilot work are that similar out-
comes may be achieved in those undertaking inpatient
rehabilitation [19]. If positive changes may be induced
during inpatient rehabilitation, this may allow some
stroke survivors to regain levels of function that are suf-
ficient to enable progression to interventions such as
constraint induced movement therapy.
This study will also allow the impact of augmenting
training with electrical stimulation to be assessed in the
context of severe motor disability. This will be the first
large study to determine the effect of outcome-triggered
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vivor is rewarded for performing the desired movement,
rather than for simply generating sufficient levels of
EMG i.e. regardless of the functional consequences.
Findings from this study will provide insights into the
effects of practice on regaining motor skill in those with
severe upper limb disability following stroke. The collec-
tion of detailed training data will generate new know-
ledge regarding the importance of specific training
elements, such as load and feedback on performance in
the early phase of rehabilitation. These will have implica-
tions that extend beyond the current modes of training
investigated and possibly to other populations such as
those with other forms of brain injury.Consent
Written informed consent was obtained from the patient
for publication of the image (Figure 1). A copy of the
written consent is available for review by the Editor of
this journal.
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